These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3606073

  • 21. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H, Kubitza D, Möller JG, Delesen H.
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital.
    Berg MJ, Rose JQ, Wurster DE, Rahman S, Fincham RW, Schottelius DD.
    Ther Drug Monit; 1987 May; 9(1):41-7. PubMed ID: 3554627
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Activated charcoal in theophylline intoxication.
    Brashear RE, Aronoff GR, Brier RA.
    J Lab Clin Med; 1985 Sep; 106(3):242-5. PubMed ID: 4031629
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT.
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE, Gillilan R, Watson WA.
    J Toxicol Clin Toxicol; 1992 Jun; 30(4):549-56. PubMed ID: 1433426
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
    Hoffman A, Levy G.
    Pharm Res; 1990 Mar; 7(3):242-6. PubMed ID: 2339096
    [Abstract] [Full Text] [Related]

  • 38. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid.
    el-Bahie N, Allen EM, Williams J, Routledge PA.
    Br J Clin Pharmacol; 1985 Jun; 19(6):836-8. PubMed ID: 4027125
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS, Mauro VF, Brown DL, Somani P.
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [Abstract] [Full Text] [Related]

  • 40. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M, Virtanen R, Iisalo E.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.